Screening, Treatment, and Prostate Cancer Mortality in the Seattle Area and Connecticut: Fifteen-year Follow-up
- 16 September 2008
- journal article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 23 (11), 1809-1814
- https://doi.org/10.1007/s11606-008-0785-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Utility of the SEER-Medicare data to identify medical androgen deprivation therapyJournal of Clinical Oncology, 2006
- American Cancer Society Guidelines for the Early Detection of Cancer, 2006CA: A Cancer Journal for Clinicians, 2006
- An Ecologic Study of Prostate-specific Antigen Screening and Prostate Cancer Mortality in Nine Geographic Areas of the United StatesAmerican Journal of Epidemiology, 2004
- Decreasing mortality rates for prostate cancer: possible role of hormonal therapy?BJU International, 2004
- The Prostate Cancer ConundrumJNCI Journal of the National Cancer Institute, 2003
- Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and ConnecticutBMJ, 2002
- Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence TrendsJNCI Journal of the National Cancer Institute, 2002
- Impact of Screening on Incidence and Mortality of Prostate Cancer in the United StatesEpidemiologic Reviews, 2001
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival RatesJNCI Journal of the National Cancer Institute, 1999
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part II: Cause of Death Misclassification and the Recent Rise and Fall in Prostate Cancer MortalityJNCI Journal of the National Cancer Institute, 1999